Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services symbols : Qnrx save search
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
Published: 2024-03-13 (Crawled : 20:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: -3.45%
H: 1.51%
C: -10.71%
update pharmaceuticals financial results
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 12.61%
H: 2.16%
C: -11.94%
conference update pharmaceuticals financial results
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: -44.48%
H: 8.07%
C: -6.83%
million offering pharmaceuticals
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
Published: 2024-03-04 (Crawled : 13:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 113.71%
H: 4.39%
C: -51.01%
fda clearance ongoing pharmaceuticals
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product
Published: 2024-02-08 (Crawled : 13:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 0.3%
H: 1.79%
C: 0.0%
patent international pharmaceuticals
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
Published: 2023-12-13 (Crawled : 13:30) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 5.38%
H: 4.77%
C: -6.33%
qrx003 fda clearance pharmaceuticals
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results
Published: 2023-11-08 (Crawled : 23:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 7.12%
H: 0.0%
C: -14.36%
update pharmaceuticals financial results
Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET
Published: 2023-11-03 (Crawled : 12:30) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: -2.79%
H: 11.0%
C: 6.46%
conference update pharmaceuticals financial results
REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
Published: 2023-10-24 (Crawled : 13:30) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 1.09%
H: 9.17%
C: 6.88%
positive pharmaceuticals trial
Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
Published: 2023-10-24 (Crawled : 12:30) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 1.09%
H: 9.17%
C: 6.88%
positive pharmaceuticals trial
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results
Published: 2023-08-02 (Crawled : 21:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 1.71%
H: 8.11%
C: 4.48%
update pharmaceuticals financial results
Quoin Pharmaceuticals Announces Second Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday August 3rd at 8:30 am ET
Published: 2023-07-27 (Crawled : 12:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 9.96%
C: 0.0%
conference update pharmaceuticals financial results
Quoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical Trial
Published: 2023-05-24 (Crawled : 12:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: -1.59%
H: 1.79%
C: -2.17%
label pharmaceuticals trial
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Results
Published: 2023-05-08 (Crawled : 21:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: -3.68%
H: 0.46%
C: -10.96%
update pharmaceuticals financial results
Quoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ET
Published: 2023-05-02 (Crawled : 12:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 1.03%
H: 4.08%
C: -2.02%
conference update pharmaceuticals financial results
Quoin Pharmaceuticals Doses First Patient in Open Label Netherton Syndrome Clinical Trial
Published: 2023-03-21 (Crawled : 13:20) - biospace.com/
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 0.08%
H: 4.02%
C: 3.98%
label pharmaceuticals trial
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-03-08 (Crawled : 00:00) - biospace.com/
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: -3.57%
H: 7.41%
C: 6.48%
pharmaceuticals year financial update results
Quoin Pharmaceuticals Announces 2022 Corporate Update Conference Call to be held on Thursday March 9th at 8:30am ET
Published: 2023-03-02 (Crawled : 21:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: -3.14%
H: 10.0%
C: 4.08%
pharmaceuticals conference update
Quoin Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
Published: 2023-02-22 (Crawled : 14:00) - globenewswire.com
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: -41.6%
H: 7.74%
C: -10.79%
offering pharmaceuticals
Quoin Pharmaceuticals Announces Dosing of First Patient in Clinical Trial in Netherton Syndrome
Published: 2022-12-13 (Crawled : 14:00) - biospace.com/
QNRX | $0.6321 -4.23% -4.27% 55K
|
Professional, Scientific, and T...
|
| O: 8.67%
H: 0.61%
C: -5.52%
pharmaceuticals trial
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.